Medication info
Duo-M 40/10 mg Tablet

Duo-M 40/10 mg Tablet

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
McNulty Pharmaceuticals Co., Ltd.
Appearance
Biconvex oval double-coated tablet in white and light blue.
Packaging
30 tablets (10 tablets/PTP*3)
Approval status
Active

MFDS item code 201904300 · Approved 2019.06.21 · Insurance code 641502820

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this drug may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution when administering this drug’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a lower dose and the dose increased gradually.
Child dose
The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
McNulty Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with telmisartan or amlodipine.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this drug may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution when administering this drug’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a lower dose and the dose increased gradually.

Child dose

The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus if used during pregnancy, especially in the second and third trimesters, and should not be taken by women who are pregnant or may become pregnant. It is contraindicated in patients with hypersensitivity to any component, during pregnancy and breastfeeding, in patients with biliary obstruction, severe liver dysfunction, severe hypotension, severe cardiac disease, and in certain kidney disease patients. Particular caution is required in patients with primary aldosteronism, certain heart valve disorders, liver impairment, gastrointestinal disorders, renal artery hypertension, dialysis patients, and the elderly. Common side effects include dizziness and peripheral edema, and very rarely, serious side effects such as syncope or cardiac issues may occur, so any abnormal symptoms should be discussed with a doctor immediately. Taking this medication during pregnancy poses risks such as decreased fetal kidney function, delayed skull formation, and neonatal hypotension; therefore, it should be discontinued immediately upon confirmation of pregnancy. It is recommended not to take this medication while breastfeeding, and if taken, the possibility of drug transfer through breast milk should be considered. Safety and efficacy have not been established in pediatric patients under the age of 18, thus use is not recommended. Elderly patients may be more sensitive to the drug, so dosage should be adjusted and monitored closely. In cases of overdose, severe hypotension, dizziness, and cardiac dysfunction may appear, necessitating immediate hospital care for appropriate treatment. This medication may interact with other drugs, so it is necessary to consult a doctor or pharmacist when taking potassium supplements, certain cardiac medications, or non-steroidal anti-inflammatory drugs simultaneously. Additionally, caution is advised when driving or operating machinery due to possible dizziness or drowsiness.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 102 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • hypoesthesia
  • taste disorders
  • tremors
  • extrapyramidal disorders
  • muscle hypertonia
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver damage
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • sweating
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • acute kidney injury
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased serum creatinine
  • weight gain
  • weight loss
  • increased serum uric acid
  • increased serum creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in an opaque container. It is also important to maintain a temperature between 1 and 30 degrees Celsius when storing the medication to preserve its effectiveness.

Appearance and packaging

Appearance

Biconvex oval double-coated tablet in white and light blue.

Package unit

30 tablets (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.